Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Nutritional Epidemiology

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1657426

This article is part of the Research TopicInteractions Between Diet, Sleep and Musculoskeletal Health: Beyond a Disease-Specific PerspectiveView all 5 articles

Association between dietary animal-derived branched-chain amino acids and sarcopenia in older adults: a cross-sectional study based on Chinese community

Provisionally accepted
Tianfeng  ZhangTianfeng Zhang1,2,3Caiyan  ZhangCaiyan Zhang1,2,3Hongzhen  DuHongzhen Du2,3Yaping  ChangYaping Chang1,2,3Kaijia  ZhaoKaijia Zhao2,3Hongmei  XueHongmei Xue2,3Mingyue  LiangMingyue Liang2,3Zengning  LiZengning Li1,2,3*
  • 1Hebei Medical University School of Public Health, Shijiazhuang, China
  • 2The First hospital of Hebei Medical University, Shijiazhuang, China
  • 3Hebei Province Key Laboratory of Nutrition and Health, Shijiazhuang, China

The final, formatted version of the article will be published soon.

Background: The free-living dietary intake of branched-chain amino acids (BCAAs, including leucine, isoleucine, and valine) may have an impact on sarcopenia. This study aimed to compare the dietary BCAAs of animal sources related to sarcopenia in older individuals aged ≥55 years living in Chinese communities. Method: We enrolled 367 older individuals (112 males and 255 females) aged over 55 years in 6 communities. Sarcopenia was diagnosed based on Asian Working Group for Sarcopenia (AWGS2019). The free-living dietary intake of BCAAs was evaluated by using a 64-item food frequency questionnaire (FFQ). Multivariable logistic regression models were applied to examine the association between BCAAs and sarcopenia. Results: The overall prevalence of sarcopenia was 20.7% (76 in 367). The mean daily energy intake, protein, fat, and BCAAs were significantly lower in the sarcopenia older adults than in the non-sarcopenia group (p < 0.05). Logistic regression analysis revealed that increased intake of leucine (OR: 0.121, 95% CI: 0.045-0.327, p < 0.001), isoleucine (OR: 0.160; 95% CI: 0.061-0.421, p < 0.001), and valine (OR: 0.202; 95% CI: 0.076-0.534, p = 0.001) were associated with the decrease risk of sarcopenia. When stratified by food sources, animal-derived BCAAs intake was significantly associated with sarcopenia in older adults (OR: 0.819; 95% CI: 0.675-0.995, p = 0.044). However, no such association was found for plant-derived BCAAs (OR: 0.903; 95% CI: 0.742-1.098, p = 0.305). Conclusion: High intake of dietary BCAAs was strongly associated with lower risk of sarcopenia in older adults. Animal-derived BCAAs intake may decrease the risk of sarcopenia in older adults, whereas no such effect was observed for plant-derived BCAAs.

Keywords: Sarcopenia, branched-chain amino acid, Animal-derived, Aging, dietary

Received: 01 Jul 2025; Accepted: 03 Sep 2025.

Copyright: © 2025 Zhang, Zhang, Du, Chang, Zhao, Xue, Liang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zengning Li, Hebei Medical University School of Public Health, Shijiazhuang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.